Search results
Psoriasis: Features That May Affect Biologic Rx Outcomes
Medscape· 4 days agoSeveral clinical characteristics were negatively associated with responses to biologics in a...
J&J (JNJ) Seeks Expanded Use of Tremfya for Crohn's Disease
Zacks via Yahoo Finance· 6 hours agoJ&J (JNJ) seeks label expansion for Tremfya for treating moderately to severely active Crohn's...
Vanguard Group Inc. Acquires 6,572 Shares of Amgen Inc. (NASDAQ:AMGN)
ETF DAILY NEWS· 4 days agoVanguard Group Inc. boosted its position in Amgen Inc. (NASDAQ:AMGN – Free Report) by 0.0% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission ...
FDA Approves Skyrizi for Ulcerative Colitis
Medscape· 3 days agoThe approval is the fourth indication for the anti–interleukin 23 monoclonal antibody after approval for Crohn's disease, psoriatic arthritis, and plaque...
In a 'gold rush' for treating bowel disease, AbbVie clears one more stage
Crain s Chicago Business· 2 days agoWith the arrival of biosimilar competition for its blockbuster drug Humira, AbbVie has said much of its sales growth potential lies with these two anti-inflammatories. In April, the North Chicago ...
AbbVie stock price forecast: $200 on the cards? | Invezz
Invezz· 1 day agoThis approval is a significant milestone, making Skyrizi now available for four different conditions in the U.S., including psoriatic arthritis, plaque psoriasis& ...
Johnson & Johnson submits application to U.S. FDA seeking approval of TREMFYA® (guselkumab) for the...
Morningstar· 23 hours agoJohnson & Johnson (NYSE: JNJ) today announced the submission of a supplemental Biologics License Application (sBLA) to the U.S. Food and Drug Administration (FDA) seeking approval of TREMFYA ...
Biogen Inc. (NASDAQ:BIIB) Shares Bought by FIL Ltd
ETF DAILY NEWS· 7 days agoFIL Ltd raised its position in Biogen Inc. (NASDAQ:BIIB – Free Report) by 936.4% during the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 656,502 shares of ...
Livelsberger Financial Advisory Invests $26,000 in Biogen Inc. (NASDAQ:BIIB)
ETF DAILY NEWS· 3 days agoLivelsberger Financial Advisory purchased a new position in shares of Biogen Inc. (NASDAQ:BIIB – Free Report) during the fourth quarter, according to the company in its most recent disclosure ...
Gerber LLC Makes New $342,000 Investment in Amgen Inc. (NASDAQ:AMGN)
ETF DAILY NEWS· 4 days agoGerber LLC bought a new stake in Amgen Inc. (NASDAQ:AMGN – Free Report) during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission ...
